Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fnmol.2022.941528
PubMed Identifier: 35836547
Publication URI: http://europepmc.org/abstract/MED/35836547
Type: Journal Article/Review
Parent Publication: Frontiers in Molecular Neuroscience
ISSN: 1662-5099